CHIMERIX INC (30)

Browse by Contract Category

Contracts

Contract modification No (Filed With SEC on May 6, 2021)
Contract modification No. 64, dated January 26, 2021 to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on February 25, 2021)
Agreement and Plan of Merger, dated January 7, 2021, by and among the Company, Oncoceutics, Merger Sub and Fortis Advisors, LLC solely in its capacity as Securityholders... (Filed With SEC on January 13, 2021)
Second Amendment to Lease Agreement, dated July 30, 2020, by and between the Registrant and CLPF-Research Center, LLC (Filed With SEC on August 10, 2020)
Open Market Sale Agreement (Filed With SEC on August 10, 2020)
Chimerix, Inc. Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2020)
License Agreement, dated September 30, 2019, by and between the Registrant and SymBio Pharmaceuticals Limited (Filed With SEC on November 5, 2019)
Underwriting Agreement, dated January 20, 2021, by and among Chimerix, Inc. and Jefferies LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on January 21, 2021)
Promissory Note, dated January 7, 2021, by and between the Company and Fortis Advisors, LLC, solely in its capacity as Securityholders Representative (Filed With SEC on January 13, 2021)
Amendment to the Supply Agreement, dated December 16, 2020, by and between Chimerix, Inc. and Scientific Protein Laboratories, LLC (Filed With SEC on December 23, 2020)
Contract modification No. 29, dated September 11, 2015, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on November 5, 2020)
Contract modification No. 28, dated September 1, 2015, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on November 5, 2020)
Contract modification No. 63, dated September 28, 2020, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on November 5, 2020)
Contract modification No. 62, dated September 11, 2020, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on November 5, 2020)
Contract modification No. 60, dated June 17, 2020, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on August 10, 2020)
Ninth Amendment to Office Lease, dated June 24, 2020, by and between the Registrant and BRI 1875 Meridian, LLC (Filed With SEC on August 10, 2020)
Contract modification No. 61, dated July 28, 2020, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on August 10, 2020)
Contract modification No. 59, dated May 11, 2020, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United States... (Filed With SEC on August 10, 2020)
Contract modification No. 58, dated December 13, 2019, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on February 25, 2020)
Supply Agreement, dated October 2, 2015, by and between the Registrant (as successor to Cantex Pharmaceuticals, Inc.) and Scientific Protein Laboratories LLC (Filed With SEC on November 5, 2019)
License and Development Agreement, dated July 26, 2019, by and between the Registrant and Cantex Pharmaceuticals, Inc (Filed With SEC on November 5, 2019)
Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise for Inducement Grant Outside of 2013 Equity Incentive Plan (Filed With SEC on August 8, 2019)
Contract modification No. 57, dated July 12, 2019, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on August 8, 2019)
Agreement and Release, dated June 6, 2019, by and between the Registrant and Timothy W. Trost (Filed With SEC on August 8, 2019)
Investors Rights Agreement between Chimerix, Inc. and Cantex Pharmaceuticals, Inc., dated July 26, 2019 (Filed With SEC on July 31, 2019)
Contract modification No. 56, dated March 5, 2019, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on May 9, 2019)
Contract modification No. 55, dated January 10, 2019, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on March 5, 2019)
Employment Offer Letter to Michael A. Alrutz dated May 9, 2012 (Filed With SEC on March 5, 2019)
Agreement and Release, dated February 8, 2019, by and between the Registrant and M. Michelle Berrey (Filed With SEC on March 5, 2019)
Contract modification No. 54, dated December 3, 2018, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on March 5, 2019)